Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSThree Regulatory News (STEM)

Share Price Information for SThree (STEM)

Share Price is delayed by 15 minutes
Get Live Data
170.20    -0.20 (-0.12%)
Bid:
170.00
Ask:
170.80
Spread: 0.80 (0.471%)
Market Cap: £208.86m
STEM Live PriceLast checked at - London Stock Exchange

Intraday SThree Share Chart

SThree: Director/PDMR Shareholding

16 Mar 2021 11:47

SThree (STEM) SThree: Director/PDMR Shareholding 16-March-2021 / 11:46 GMT/BST Dissemination of a Regulatory Announcement that contains inside information according to REGULATION (EU) No 596/2014 (MAR), transmitted by EQS Group. The issuer is solely responsible for the content of this announcement.


Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1. Details of the person discharging managerial responsibilities / person closely associated

 

a) Names

 

Mark Dorman

 

 

2. Reason for the notification

 

a) Position/status

 

 

CEO

b) Initial notification /Amendment

 

Initial notification

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a) Name

 

 

SThree plc

 

b) LEI

 

2138003NEBX5VRP3EX50

4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a) Description of the financial instrument, type of instrument

Identification code

 

Ordinary shares of 1p

GB00B0KM9T71

b) Nature of the transaction

 

 

A performance share award under the Long Term Incentive Plan ("LTIP") has been granted at 362p per share. The award will vest three years after grant date, subject to the performance conditions being met. Performance targets and target ranges are set out as follows:

LTIP targets

EPS

TSR vs. peer group

Strategic

2021-2023

2023 EPS to be between 24.9p (25% vesting) and 38.9p (100% vesting)

2021 - 2023 performance between median (25% vesting) and upper quartile (100% vesting)

2023 adjusted operating profit conversion ratio between 14.2% (25% vesting) and 21.0% (100% vesting)

 

c) Price(s) and volume(s)

 

 

 

Names

 

Mark Dorman

Volume(s)

 

200,563

d) Aggregated information

- Aggregated volume

- Price

N/A

e) Date of the transaction

 

16/03/2021

f) Place of the transaction

London

 


ISIN:GB00B0KM9T71
Category Code:DSH
TIDM:STEM
LEI Code:2138003NEBX5VRP3EX50
OAM Categories: 3.1. Additional regulated information required to be disclosed under the laws of a Member State
Sequence No.:95635
EQS News ID:1175982
 
End of AnnouncementEQS News Service

UK Regulatory announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.

Date   Source Headline
2nd Mar 202611:15 amRNSTotal Voting Rights
2nd Mar 20267:00 amRNSTransaction in Own Shares
27th Feb 20267:00 amRNSTransaction in Own Shares
26th Feb 20267:00 amRNSTransaction in Own Shares
25th Feb 20267:00 amRNSTransaction in Own Shares
24th Feb 20267:00 amRNSTransaction in Own Shares
23rd Feb 20267:00 amRNSTransaction in Own Shares
20th Feb 20267:00 amRNSTransaction in Own Shares
19th Feb 20267:00 amRNSTransaction in Own Shares
18th Feb 20267:00 amRNSTransaction in Own Shares
17th Feb 20267:00 amRNSTransaction in Own Shares
16th Feb 20267:00 amRNSTransaction in Own Shares
13th Feb 202612:15 pmRNSDirector/PDMR Shareholding
13th Feb 20267:00 amRNSTransaction in Own Shares
12th Feb 20267:00 amRNSCommencement of Share Buyback Programme
2nd Feb 20261:24 pmRNSTotal Voting Rights
27th Jan 20267:00 amRNSFY25 Final Results
13th Jan 20269:08 amRNSDirector/PDMR Shareholding
2nd Jan 202611:56 amRNSTotal Voting Rights
2nd Jan 202611:45 amRNSPurchase of shares into the EBT
2nd Jan 202610:56 amRNSHolding(s) in Company
19th Dec 20254:23 pmRNSHolding(s) in Company
19th Dec 20254:23 pmRNSHolding(s) in Company
19th Dec 20254:19 pmRNSDirector/PDMR Shareholding
19th Dec 20254:19 pmRNSDirector/PDMR Shareholding
16th Dec 20257:00 amRNSFY25 Full Year Trading Update
15th Dec 20252:11 pmRNSHolding(s) in Company
15th Dec 202510:14 amRNSDirector/PDMR Shareholding
11th Dec 20254:28 pmRNSHolding(s) in Company
9th Dec 20255:35 pmRNSHolding(s) in Company
1st Dec 202512:14 pmRNSTotal Voting Rights
26th Nov 20258:00 amRNSDirector Declaration
26th Nov 20257:00 amRNSDirectorate change
13th Nov 20253:40 pmRNSDirector/PDMR Shareholding
7th Nov 20253:57 pmRNSHolding(s) in Company
31st Oct 202511:42 amRNSTotal Voting Rights
24th Oct 20259:37 amRNSHolding(s) in Company
22nd Oct 20251:03 pmRNSHolding(s) in Company
14th Oct 20254:28 pmRNSDirector/PDMR Shareholding
6th Oct 202511:04 amRNSDirector Declaration
1st Oct 202512:09 pmRNSResult of Meeting
30th Sep 202512:48 pmRNSTotal Voting Rights
26th Sep 202510:41 amRNSHolding(s) in Company
17th Sep 20259:30 amRNSDirector/PDMR Shareholding
16th Sep 20257:00 amRNSFY25 Q3 Trading Update
15th Sep 202511:00 amRNSDirector/PDMR Shareholding
10th Sep 20251:59 pmRNSHolding(s) in Company
10th Sep 202510:45 amRNSHolding(s) in Company
5th Sep 20257:00 amRNSNotice of GM
1st Sep 202511:03 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.